DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Dixon Technologies (India) Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·10 Oct 2026, 8:11 am

Dixon Technologies (India)

Dixon Technologies (India) Limited recently held a meeting with analysts and institutional investors. During this session, the company management likely discussed its current business performance, future growth strategies, and outlook for the sector. Such interactions allow the company to communicate directly with the investment community and address queries regarding its operations.

For investors, these updates are significant as they provide clarity on the company's direction and help validate market expectations. Positive insights from management can boost investor confidence, while any guidance on specific business segments may offer signals about potential future performance.

Moving forward, investors should focus on the specific guidance provided by Dixon regarding its order book, export demand, and new product launches. Keeping an eye on the company's quarterly results will also be crucial to see if the management's optimism aligns with actual execution and market trends.